15.36
Hercules Capital Inc stock is traded at $15.36, with a volume of 783.14K.
It is down -1.00% in the last 24 hours and down -0.03% over the past month.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
See More
Previous Close:
$15.49
Open:
$15.44
24h Volume:
783.14K
Relative Volume:
0.44
Market Cap:
$2.87B
Revenue:
$514.85M
Net Income/Loss:
$328.86M
P/E Ratio:
8.6478
EPS:
1.7756
Net Cash Flow:
$311.25M
1W Performance:
-1.00%
1M Performance:
-0.03%
6M Performance:
-16.61%
1Y Performance:
-14.85%
Hercules Capital Inc Stock (HTGC) Company Profile
Name
Hercules Capital Inc
Sector
Industry
Phone
650-289-3060
Address
1 NORTH B STREET, SAN MATEO, CA
Compare HTGC vs BLK, BX, BN, KKR, APO
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HTGC
Hercules Capital Inc
|
15.36 | 2.90B | 514.85M | 328.86M | 311.25M | 1.7756 |
|
BLK
Blackrock Inc
|
1,056.86 | 163.01B | 26.28B | 6.75B | 3.76B | 38.77 |
|
BX
Blackstone Inc
|
124.22 | 151.21B | 14.88B | 6.10B | 869.79M | 3.8977 |
|
BN
Brookfield Corp
|
43.99 | 99.26B | 77.61B | 4.06B | -8.36B | 0.497 |
|
KKR
Kkr Co Inc
|
97.06 | 87.10B | 22.38B | 5.74B | 8.54B | 2.9339 |
|
APO
Apollo Global Management Inc
|
136.03 | 79.27B | 31.69B | 2.94B | 8.43B | 1.5206 |
Hercules Capital Inc Stock (HTGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-04-25 | Upgrade | Compass Point | Neutral → Buy |
| Dec-12-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Jan-16-24 | Downgrade | Compass Point | Buy → Neutral |
| Nov-21-23 | Initiated | UBS | Neutral |
| Aug-30-23 | Upgrade | Compass Point | Neutral → Buy |
| Aug-04-23 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Apr-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-13-23 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jul-29-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-22-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Apr-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-08-22 | Downgrade | Compass Point | Buy → Neutral |
| Apr-28-21 | Initiated | Oppenheimer | Outperform |
| Mar-25-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-20 | Resumed | JMP Securities | Mkt Outperform |
| Jul-31-20 | Upgrade | Compass Point | Neutral → Buy |
| Jul-20-20 | Resumed | Piper Sandler | Overweight |
| Jun-19-20 | Upgrade | Janney | Neutral → Buy |
| Mar-31-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-04-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| May-06-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Mar-13-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Mar-13-19 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Feb-07-18 | Upgrade | Wedbush | Neutral → Outperform |
| Feb-06-18 | Upgrade | Sandler O'Neill | Hold → Buy |
| Nov-20-17 | Initiated | Ladenburg Thalmann | Buy |
| Nov-03-17 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Oct-25-17 | Initiated | Wedbush | Neutral |
| Oct-02-17 | Resumed | FBR & Co. | Buy |
| Sep-08-17 | Upgrade | Compass Point | Neutral → Buy |
| Aug-07-17 | Resumed | JMP Securities | Mkt Outperform |
| Aug-04-17 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Feb-24-17 | Reiterated | FBR & Co. | Outperform |
View All
Hercules Capital Inc Stock (HTGC) Latest News
Hercules Capital Faces Its Own 12 Labors (NYSE:HTGC) - Seeking Alpha
Technical Reactions to HCXY Trends in Macro Strategies - Stock Traders Daily
HTGC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
What's Behind the Sudden Surge in Bearish Bets on Hercules Capital - Kavout
Hercules Capital, Inc. 2026 Annual Meeting Results: Director Election, Executive Compensation, and Equity Plan Amendments Approved - Minichart
Hercules Capital Inc (HTGC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Hercules Capital (HCXY) investors back director, pay plans and auditor at 2026 meeting - Stock Titan
Hercules Capital (HTGC) AGM 2026 Summary - Quartr
Hercules Capital Inc (HTGC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Hercules Capital Inc (HTGC) Institutional Confidence - TradingKey
Hercules Capital Inc (HTGC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Hercules Capital Inc (HTGC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc. - Investing News Network
Dyne Therapeutics Expands Hercules Capital Debt Facility to Up to $400 Million - citybiz
Behavox Raises $175 Million from HPS Investment Partners, Part of BlackRock, to Accelerate Global Growth - Business Wire
Lawsuit ALERT: Investors Who Hold Shares of Hercules Capital, Inc. (NYSE:HTGC) Should Contact the Shareholders Foundation - Newswire.com
Dyne Therapeutics Expands Loan Facility to $400 Million with Hercules Capital Amendment - marketscreener.com
Dyne Therapeutics amends loan facility, secures $50 million - Investing.com UK
Dyne Therapeutics amends loan facility, secures $50 million By Investing.com - Investing.com Australia
Biotech Dyne adds $400M debt to advance two rare disease drugs - Stock Titan
Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Hercules Capital Inc (HTGC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Hercules Capital Inc (HTGC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Hercules Capital Inc (HTGC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hercules Capital Inc (HTGC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Liquidity Mapping Around (HTGC) Price Events - Stock Traders Daily
HCXY Q1 2026 Earnings: EPS Misses Estimates by 1.28%, Shares Edge HigherQuarterly Profit Report - lwvtexas.org
HTGC Lawsuit Alleges Company Allegedly Copied Deal Sourcing ProcessHercules Capital Investors Face Losses Following Company Allegedly Copied Deal Sourcing Process-- Hagens Berman - Eastern Progress
Watkins Advises Hercules Capital in an Up to US$300 Million Growth Financing for Leading Biotech Beren Therapeutics - Latham & Watkins LLP
Beren Therapeutics secures $300 million in financing By Investing.com - Investing.com Australia
Hercules Capital (NYSE: HTGC) CFO reports minor tax-related share withholding - Stock Titan
Trading the Move, Not the Narrative: (HCXY) Edition - Stock Traders Daily
Beren Therapeutics secures $300 million in financing - Investing.com
Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C - Stock Titan
Hercules Capital: Attractive Valuation And Growth Potential (NYSE:HTGC) - Seeking Alpha
Should Hercules Capital’s Earnings Beat and Record Commitments Shift the Risk‑Reward for HTGC Investors? - Sahm
Hercules Capital (HTGC) Stock Moves -1.86%: What You Should Know - Yahoo Finance
Is Hercules Capital (HTGC) Now Priced Attractive After Recent Share Price Weakness - Yahoo Finance
Why (HTGC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Hercules Capital (HTGC) Down 7.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Perk secures $300m credit facility to fund expansion By Investing.com - Investing.com Australia
Perk secures $300m credit facility to fund expansion - Investing.com UK
$300M bet on AI business travel: Perk fuels global expansion - Stock Titan
Hercules Capital director Randhawa buys $45k in shares - Investing.com
HTGC Q1 2026 Earnings: Earnings Slightly Miss Estimates as Stock Declines 1.08%Pre-Earnings Drift - newsline.com
(HCXY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Hercules Capital (HTGC) CFO discloses 30,386 shares and 25,756 RSUs - Stock Titan
1 Small-Cap Stock with Exciting Potential and 2 We Ignore - Yahoo Finance
TriplePoint Venture Growth: Another Dividend Cut Likely (NYSE:TPVG) - Seeking Alpha
Volatility, lower venture valuations drive record Q1 originations – Hercules Capital - PitchBook
Specialty Finance Stocks Q1 Teardown: Hercules Capital (NYSE:HTGC) Vs The Rest - Yahoo Finance
Hercules Capital Inc Stock (HTGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):